• Explore /
  • Poster
  • / Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.

Systematic high-throughput combination drug screen to enhance poly (ADP-ribose) polymerase (PARP) inhibitor efficacy in ovarian cancer.

Abstract Poster

Authors

Katherine Foster

Katherine Foster

The University of Texas MD Anderson Cancer Center, Houston, TX

Katherine Foster , Santosh K. Dasari , Reid T. Powell , Nghi D. Nguyen , Mary Sobieski , Clifford Stephan , Ashwani Bahl , Timothy A. Yap , Amir A. Jazaeri , Shannon Neville Westin , Anil K Sood

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5546)

DOI

10.1200/JCO.2023.41.16_suppl.5546

Abstract #

5546

Poster Bd #

241

Abstract Disclosures

Similar Posters

First Author: Lorena Incorvaia

First Author: Joseph W. Kim

First Author: Rachel M Hurley

First Author: Charles J. Ryan